Pfizer Says Its Covid Pill, Paxlovid, Will Protect Against Severe Diseasenews2021-12-14T12:23:59+00:00December 14th, 2021|The New York Times|
Los nuevos antivirales para la covid ofrecen esperanza frente a la variante ómicronnews2021-12-08T15:49:42+00:00December 8th, 2021|The New York Times|
Antiviral Covid-19 Pills Are Coming. Will There Be Enough Tests?news2021-11-29T19:40:28+00:00November 29th, 2021|The New York Times|
F.D.A. Authorizes Coronavirus Booster Shots for All Adultsnews2021-11-19T21:45:01+00:00November 19th, 2021|The New York Times|
F.D.A. Authorizes Covid Booster Shots for All Adultsnews2021-11-19T21:44:59+00:00November 19th, 2021|The New York Times|
Biden Administration Plans to Expand Covid Vaccine Productionnews2021-11-18T00:41:23+00:00November 18th, 2021|The New York Times|
U.S. to Buy Enough of Pfizer’s Covid Antiviral Pills for 10 Million Peoplenews2021-11-17T02:47:01+00:00November 17th, 2021|The New York Times|
F.D.A. Plans to Authorize Pfizer Boosters for All Adults This Weeknews2021-11-17T01:17:59+00:00November 17th, 2021|The New York Times|
Pfizer Asks F.D.A. to Authorize Covid Pill For High-Risk Unvaccinated Peoplenews2021-11-17T00:40:29+00:00November 17th, 2021|The New York Times|
Pfizer Will Allow Its Covid Pill to Be Made and Sold Cheaply in Poor Countriesnews2021-11-16T21:00:17+00:00November 16th, 2021|The New York Times|
